Difluprednate Emulsion
Product Images NDC 0832-6054
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Difluprednate (NDC 0832-6054). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Upsher-smith Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure (Difluprednate 02)
Figure (Difluprednate 03)
This text appears to be a chart displaying the percentage of subjects who were pain-free on different days after using Difiuprednate Ophthalmic Emulsion compared to a placebo. The subjects were evaluated on Day 3, Day 8, and Day 15. The chart shows that 25% of subjects were pain-free on Day 3, 27% on Day 8, and 63% on Day 15. The group size for the Difiuprednate Ophthalmic Emulsion was n=107, while the placebo group size was n=220. The asterisk (*) indicates statistical significance at a p-value of less than 0.05.*
Principal Display Panel (5 mL Bottle Carton)
This is a product label for Difluprednate Ophthalmic Emulsion 0.05%, intended for ophthalmic use only. It contains active ingredient Difluprednate 0.06% with preservative and inactive ingredients. The usual dosage is specified on the packaging set or prescribing information. It should be stored between 15° to 25°C and protected from light. Distributed by Upsher-Smith Laboratories, LLC. The text also includes copyright and NDC numbers for identification.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.